|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Kynam Capital Management LP
✚
|
|
|---|---|
| CRD # | 314368 |
| SEC # | 801-126187 |
| CIK # | 0001907884 |
| AUM | $2.6 B (2025-03-28) |
| Employees | 3 (67% Investors, 0% Brokers) |
| Phone | 574-315-9016 |
| Address | |
| Source | [IAPD] [EDGAR] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Celldex Therapeutics Inc | 124.1 | ||
| Vaxcyte Inc | 99.9 | ||
| Vera Therapeutics Inc | 80.7 | ||
| Syndax Pharmaceuticals Inc | 79.8 | ||
| Biocryst Pharmaceuticals Inc | 75.8 | ||
| CG Oncology Inc | 63.9 | ||
| Signal Genetics Inc | 61.9 | ||
| UNUM Therapeutics Inc | 61.0 | ||
| Beam Therapeutics Inc | 41.1 | ||
| Immunocore Holdings PLC | 30.6 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Kynam Global Healthcare Master Fund LP | [2021-04-12] | 64.7 | 2,176.0 |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 6 | 2.6 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 6 | 2.6 |
| By Discretionary | ||
| Discretionary | 6 | 2.6 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 2.6 |
| By Non-United States Persons | ||
| Non-United States Persons | 1.6 | |
| United States Persons | 0.9 | |
| Total | 6 | 2.6 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Robert Meschi | 126 | ||
| Richard Ruffer | 361 | ||
| Yue Tang | 2 | ||
| Kynam Capital Management LP | 2 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001907884] | |
| 3 | [0001907884] | |
| 4 | [0001907884] | |
| SC 13G | [0001907884] |
| Form 3/4/5 Subject | 2011 - 2025 |
|---|---|
| 2seventy bio, Inc. | |
| Kynam Capital Management GP, LLC | |
| Kynam Global Healthcare Master Fund, LP | |
| Kynam Fund GP, LLC | |
| Kynam Capital Management, LP | |
| Tang Yue |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Sourcerock Group LLC
✚
|
CO | 2.6 |
|
Sound Point Commercial Real Estate Finance LLC
✚
|
NY | 2.6 |
|
Pointer Management LLC
✚
|
TN | 2.6 |
|
Steelhead Partners LLC
✚
|
WA | 2.6 |
|
Bain Capital Partnership Strategies LP
✚
|
MA | 2.6 |
|
HITE Hedge Asset Management LLC
✚
|
MA | 2.6 |
|
Park West Asset Management LLC
✚
|
CA | 2.5 |
|
Concentric Capital Strategies LP
✚
|
CT | 2.5 |
|
Row Asset Management LLC
✚
|
CA | 2.5 |
|
Burkehill Global Management LP
✚
|
NY | 2.5 |